Highlights Ajanta Pharma Limited Bombay S.E.

Equities

AJANTPHARM

INE031B01049

Market Closed - Bombay S.E. Other stock markets 06:00:53 2024-06-19 am EDT			5-day change	1st Jan Change
2,372 ^INR	-1.63%		-1.22%	+13.78%

Jun. 11	Ajanta Pharma Limited's Equity Buyback announced on May 2, 2024 has expired.	CI
May. 03	INDIA STOCKS-India's Nifty 50 slips from record high as IT stocks weigh	RE

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Ajanta Pharma Limited's Equity Buyback announced on May 2, 2024 has expired.	Jun. 10	CI
INDIA STOCKS-India's Nifty 50 slips from record high as IT stocks weigh	May. 03	RE
Ajanta Pharma's Consolidated Profit Nearly Doubles in Fiscal Q4	May. 02	MT
Ajanta Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 02	CI
Ajanta Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 02	CI
Ajanta Pharma Limited announces an Equity Buyback for 1,028,881 shares, representing 0.82% for INR 2,850 million.	May. 02	CI
Ajanta Pharma Limited Provides Revenue Guidance for the Fiscal Year 2025	May. 02	CI
Ajanta Pharma Limited authorizes a Buyback Plan.	May. 01	CI
Ajanta Pharma Limited?s Board intends to launch an Equity Buyback on May 2, 2024.	Apr. 25	CI
Ex-dividend day for interim dividend	Feb. 07	FA
Ajanta Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit	Feb. 02	MT
Ajanta Pharma Limited Approves Second Interim Dividend for the Year Fiscal Year 2024, Payable on or After 19th February 2024	Jan. 31	CI
Ajanta Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 31	CI
Ajanta Pharma Board to Consider Second Interim Dividend for Fiscal 2024	Jan. 25	MT
Ajanta Pharma Limited Provides Earnings Guidance for the Full Year of Fiscal 2024	23-10-31	CI
Ajanta Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-31	CI
Ajanta Pharma Gets US FDA Nod for Topiramate Extended-Release Capsules	23-08-30	MT
Ajanta Pharma Limited Receives Final Approval from US FDA for Topiram Extended Release Capsules	23-08-30	CI
Ex-dividend day for extraordinary dividend	23-08-03	FA
Ex-dividend day for interim dividend	23-08-03	FA

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Ajanta Pharma Limited Bombay S.E.

Equities

AJANTPHARM

INE031B01049

Highlights

Filters